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Neuropeptides are key mediators of physiological processes in animals and a considerable amount of 
information has been accumulated on their diversity and functions across phyla. However, progress in 
echinoderm neurobiology has been much slower than others. The sea cucumber Holothuria scabra is an 
economically important tropical echinoderm species in which a neuropeptide is yet to be identified. This 
immunohistochemical study utilized antibody raised against GFSKLYFamide neuropeptide together with 
confocal laser scanning microscopy. GFSKLYFamide-like immunoreactivity was shown to be localized 
in the stomach and small intestines of H. scabra. This is the first report that provides evidence for the 
presence of GFSKLYFamide neuropeptide in the digestive tract of this species.  
 





The sea cucumber Holothuria scabra, also called sandfish, 
is an echinoderm species in the class Holothuroidea, 
order Aspidochirotida, family Holothuriidae and genus H. 
Metriatyla scabra (Jaeger, 1833). Other classes in the 
echinoderm phylum are starfish (Astroidea), sea urchin 
(Echinoidea), sea lilies (Crinoidea) and brittle stars 
(Ophruroidea) (Hyman, 1955). H. scabra is a premium 
sea cucumber species that is widely consumed due to its 
medicinal value but there is a threat of extinction on the 
natural population due to overexploitation in some parts 
of Asia (Bussarawit and Thongtham, 1999). Consequently, 
efforts have been made to culture H. scabra, however, 
there is little knowledge about its biology, particularly the 
neurohormonal pathway (Cobb, 1988). Neuropeptides 
are key mediators of physiological processes in animals 
and a considerable amount of information has been 
accumulated on their diversity and functions across phyla 
(Strand, 1999). Echinoderms are of phylogenetic 
importance to chordates in that they are deuterostomes. 
They exhibit some remarkable biological phenomena
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such as evisceration and regeneration, the mediation of 
which may involve neuropeptides. Although, research in 
echinoderm neurobiology has advanced at a much 
slower pace compared with that of other phyla, the 
discovery of SALMFamide peptides, which are related to 
the FMRFamide-related peptides family, in echinoderm 
species has been very encouraging (Cobb, 1988; Elphick 
et al., 1991; Walker et al., 2009). 
The tetrapeptide FMRFamide neuropeptide was 
isolated from the ganglia of a mollusc, the clam 
Macrocallista nimbosa by virtue of its cardioexcitatory 
effect and became the first known member of the 
family of FMRFamide-related peptides (Price and 
Greenberg, 1977). FMRFamide-related peptides are a 
large collection of neuropeptides found in vertebrates 
and invertebrates (Price and Greenberg, 1989; Walker 
et al., 2009). They are identified by the possession of a 
C-terminal -RFamide (-Arg-Phe-NH2) amino acid 
sequence and are often coded for by multiple genes. In 
the Caenorhabditis elegans for example, at least 22 
genes are known to encode FMRFamide-related 
peptides (Li et al., 1999). They have been implicated in 
roles that include cardiovascular function, modulation 
of muscle contraction, control of locomotor activity, 
water balance, neuroendocrine and neuromodulatory 
activities (Dockray, 2004). The effect of FMRFamide 
neuropeptide itself could be excitatory or inhibitory on 
cardiac rhythm and contractility in molluscs, depending 
on the species under investigation. It activates non-
cardiac muscles in molluscs (Greenberg and Price, 
1979). In rats, FMRF-amide excites brain stem neurons 
(Gayton, 1982) and induces the elevation of blood 
pressure (Mues et al., 1982). An FMRFamide-gated 
sodium channel, which was the first peptide-gated ion 
channel was reported in snails (Cottrell et al., 1990; 
Cottrell, 1997; Lingueglia et al., 1995), and it was shown 
in rats that brain FMRFamide-activated sodium 
channels may be involved in the mechanism of salt-
sensitive hypertension through the regulation of the 
brain renin-angiotensin system (Nishimura et al., 2000). 
The SALMFamide peptides are the first neuropeptides 
to be fully characterized and sequenced from any 
echinoderm and they share some similarities with 
FMRFamide in that they were initially discovered 
based on radioimmunoassay using antibodies against 
FMRFamide (Díaz-Miranda et al., 1992; Elphick et al., 
1991), and the presence of a Famide (-Phe-NH2) at 
their carboxyl terminal (Walker, 1992). Though it was 
noted that the FMRFamide immunoreactivity earlier 
observed in echinoderms could have been due to other 
peptide families (Díaz-Miranda et al., 1992), the 
proposed criteria by Price and Greenberg (Price and 
Greenberg, 1989) for identifying any FMRFamide-
related peptide seemed to have been met, at least in 
part, by SALMFamides. Interestingly, none of the 
newly characterized peptides possess the penultimate  




Arginine (-RFamide) motif that is signature of 
FMRFamide-related peptides hence, the notion that 
SALMFamides represent a new family of neuropeptides 
in Echinoderms, and the name „SALMFamide‟ was first 
proposed by Elphick et al. (Elphick et al., 1991). The 
first fully sequenced echinoderm SALMFamide neuro-
peptides were identified about two decades ago (Elphick 
et al., 1991). The two peptides, GFNSALMFamide (S1) 
and SGPYSFNSGLTFamide (S2), were isolated from 
the starfish Asterias rubens and Asterias forbesi both 
in the class Asteroidea. They were designated 
SALMFamides because of the conserved “SALMF” at 
the C-terminal of their amino acid sequence since they 
lack the penultimate –R motif that characterizes 
FMRFamide-related peptides. A number of SALMFamide 
peptides were also identified in other echinoderm 
species (Elphick and Thorndyke, 2005). These include 
GFNSALMFamide (S1), SGPYSMTSGLTFamide 
(MagS2), AYHSALPFamide (MagS3), and 
AYQTGLPFamide (MagS4) which were isolated from 
the starfish, Marthasterias glacialis (Yun et al., 2007). 
Interestingly, S1 was discovered in two species of 
starfish. GFSKLYFamide and SGYSVLYFamide were 
isolated from the digestive tract of the sea cucumber, 
Holothuria glaberrima and they constitute the first 
neuropeptides to be isolated from any sea cucumber 
species (Díaz-Miranda et al., 1992). However, it is yet to 
be determined if the isolated peptides from the sea 
cucumber H. glaberrima are also expressed in other 
sea cucumber species as is the case with the 
expression of S1 in starfish.  
Our study of the sea cucumber H. scabra is premised 
on it being a tropical species with high economic value. 
Moreover, adequate knowledge of the neurohormonal 
pathway of this species is important for its aquaculture 
and conservation. Of particular interest is the digestive 
system, which is critical for effective nutrition and growth 
of H. scabra under culture conditions. Unfortunately, a 
neuropeptide or peptide hormone is yet to be identified in 
this species. Hence, this project aims to determine the 
presence and distribution of GFSKLYFamide 








Adult sea cucumber H. scabra were sourced from the Andaman 
Sea at Koh Jum Island in Krabi province of Thailand. Six adult H. 
scabra used in this study have an average weight of 123 g (62 to 
175 g) and were collected at different times between May, 2009 
and April, 2010. They were maintained in filtered natural sea water 
within a temperature range of 28 to 31°C and salinity of about 32 
ppt at the Shrimp Genetic Improvement Centre, Chiya, Suratthani 
before being transferred to the laboratory in Bangkok in oxygenated 
sealed plastic bags. 
 






Polyclonal antibody against GFSKLYFamide was generously 
provided by Professor García-Arrarás (University of Puerto Rico, 
USA). The antibody was raised (as described by Díaz-Miranda et 
al., 1995), using 63 g of synthetic GFSKLYFamide coupled to 15 
mg BSA with 0.3% glutaraldehyde. The reaction was stopped by 
the addition of 1 M Glycine, and the mixture dialyzed. Aliquot of the 
dialysate BSA-GFSKLYFamide conjugate was emulsified with 
complete Freund‟s adjuvant and injected into two rabbits with half of 
the emulsion each, subcutaneously and intraperitoneally. Two 
boosters of the aliquot mixed with incomplete Freund‟s adjuvant 
were given after the initial injection and sera was collected 7 and 14 
days after each injection, preabsorbed with BSA and assayed by 
immunohistochemical reactivity on sections of sea cucumber 





Indirect immunofluorescence method was used to analyze the 
occurrence of GFSKLYFamide-like immunoreactivity in the 
digestive tract of H. scabra using frozen sections. Stomach and 
intestinal tissues of H. scabra were processed for 
immunohistochemical analysis according to a previously described 
method (Ajayi and Withyachumnarnkul, 2013). Briefly, animals were 
anaesthetized in ice for about 30 min before dissection. Dissected 
tissues were fixed immediately in 4% paraformaldehyde for 5 to 24 
h at 4°C, washed three times in PBS for 10 min each and 
cyoprotected in 30% sucrose overnight. Sections of 7 μm thickness 
were cut with a cryostat (LIECA CM 1850), mounted on poly-L-
lysine-coated slides and permeabilized in PBS-Triton X-100 (0.1%) 
for 5 min before blocking with normal goat serum (1:50 in PBS) for 
1 h. Sections were incubated overnight at room temperature with 
primary antibody (1:1000 in PBS) followed by three washes in PBS-
Tween 20 (0.05%) for 10 min each. This was followed by 1 to 2 h 
incubation in Alexa 488-conjugated goat anti-rabbit IgG (1:500 in 
PBS) at room temperature. Sections were then washed 3 times, 10 
min each, in PBS-Tween 20. Slides were incubated in TOPO-3 
(1:500 in PBS) at room temperature for 1 h then rinsed in PBS-
Tween 20 (0.05%) and mounted in buffered glycerol (pH 8.6). 
Tissues were examined and photographs taken with an Olympus 
Confocal laser scanning microscope (FV 1000). Images were 
processed using OLYMPUS FLOVIEW 1.7b viewer and Adobe 
Photoshop CS3. Preabsorption control was done by substituting the 
primary antibody with PBS or preabsorbed antibody. Working 
dilutions of GFSKLYFamide antibody (1: 1000 in PBS) were 
preabsorbed overnight at 4°C with 100, 50 and 10 ng/µl of synthetic 





In this study, portions of the stomach and descending 
intestine were examined for immunoreactivity to 
GFSKLYFamide antiserum. Histological features of the 
stomach and small intestine of H. scabra are similar to 
those of other sea cucumber species. Histologically, the 
mucosa of the digestive tract of echinoderms consists of 
pseudostratified luminal epithelium, adjacent to which 
there is a layer of internal connective tissue. The 
connective tissue layer is followed by a muscle layer and 





separates the internal connective tissue layer from the 
luminal epithelium and from the muscle layer. The muscle 
layer is usually subdivided into an inner circular muscle 
layer and an outer longitudinal layer. External connective 
tissue layer is associated with the coelomic epithelial 
layer (Garcia-Arraras et al., 2001; Hyman, 1955). Results 
show the presence of GFSKLYFamide-like immune-
reactivity in the stomach and small intestines of the sea 
cucumber H. scabra. In the stomach, GFSKLYFamide-
like immunoreactivity was localized within the 
submucosal and muscular layers. Immunoreactive cell 
bodies could also be seen in the submucosal layer 
(Figure 1). The small intestine expresses intensely 
stained immunoreactive fibers in mucosa as well as the 
coelomic epithelium, adjacent to the muscle tissue 





The digestive system of H. scabra consists of mouth, 
esophagus, stomach, ascending intestine, descending 
small intestine, large intestine, rectum, cloaca and anus, 
supported by a mesentery (Hyman, 1955; Bai, 1971). In 
this study, only the stomach and small intestines of H. 
scabra were examined for immunoreactivity against 
GFSKLYFamide neuropeptide. Results indicate wide-
spread distribution of GFSKLYFamide-like immune-
reactivity in the stomach and small intestines of the sea 
cucumber H. scabra suggesting that GFSKLYFamide 
neuropeptide might be present in the digestive tract of H. 
scabra. The expression of GFSKLYFamide-like 
immunoreactivity in the digestive tract of this species, as 
shown in this study, also provides evidence in support of 
the potential role of GFSKLYFamide neuropeptide in the 
digestive functions H. scabra. Although, this is the first 
report of the occurrence of GFSKLYFamide-like 
immunoreactivity in H. scabra, the neuropeptide has 
previously been reported in the sea cucumber H. 
glaberrima. In earlier report, GFSKLYFamide-like 
immunoreactivity was observed to be present in the 
radial nerve cords as well as in the digestive, haemal, 
respiratory and reproductive systems; in the tentacles; 
and in tube feet of H. glaberrima (Díaz-Miranda et al., 
1995). Although, the present study only examined the 
digestive system, there are some similarities in the 
expression of GFSKLYFamide immunoreactivity in 
both species. It was observed that in the intestine of H. 
glaberrima, GFSKLYFamide immunoreactive nerve 
fibres were found mainly within a dense nerve plexus 
overlying and in close contact with smooth muscle cells 
of the intestine. In the stomach, GFSKLYFamide 
immunoreactivity was observed within the internal 
connective tissue as well as in the muscular and external 
connective tissue. These observations are consistent with 
the pattern of expression of GFSKLYFamide-like 
 













Figure 1. GFSKLYFamide-like immunoreactivity in the stomach of H. scabra. 
Immunoreactivity (green), as indicated by arrows, is present in the 
submucoca layer, muscular layer and in the coelomic lining of the serosa. 
Nuclei were counterstained with TOPO-3 (red). LE = Luminal epithelium of 
the mucosa; S = Submucosa; M = muscular layer; CE = coelomic epithelium 












Figure 2. GFSKLYFamide-like immunoreactivity in the small intestine of H. 
scabra. Immunoreactivity (green) is indicated by arrows on the mucosa, 
submucosal, muscular and in the coelomic epithelium of the serosa lining. 
Nuclei were counterstained with TOPO-3 (red). Mu = Mucosa; S = 
submucosa; M = muscular layer; CE = coelomic epithelium of the serosa 
layer. Scale bar = 50 µm. 
 




immunoreactivity in H. scabra. One important difference 
between the two species though, is the presence of a 
distinct stomach in H. scabra which was said to be 
absent in H. glaberrima (Díaz-Miranda et al., 1995). 
Since the isolation of the SALMFamide neuropeptide, 
GFSKLYFamide, alongside SGYSVLYFamide, from the 
sea cucumber H. glaberrima we have begin to gain 
some insight into the activity of SALMFamides and their 
global expression in the echinoderm phylum. In H. 
glaberrima, GFSKLYFamide neuropeptide has been 
observed to cause relaxation of intestinal muscles 
(Díaz-Miranda and García-Arrarás, 1995). SALMFamide 
peptides act as inhibitory neuromuscular transmitters 
in starfish (Elphick and Melarange, 2001). They may act 
as inhibitory transmitters not only in the starfish 
neuromuscular system but also more generally in other 
parts of their nervous systems because S1 inhibits 
secretion of the hormone gonad-stimulating substance 
from the radial nerves in the starfish Asterina pectinifera 
(Mita et al., 2004). Furthermore, SALMFamides have 
been observed to be involved in feeding behavior 
(Dockray, 2004; Melarange et al., 1999).  
Investigations into the expression of SALMFamides in 
the sea cucumber Stichopus japonicus reveal the 
existence of two peptides, GYSPFMFamide and 
FKSPFMFamide (Ohtani et al., 1999). These peptides 
along with twenty others were shown to influence 
muscle activity in S. japonicus although GYSPFMFamide 
and FKSPFMFamide were the only peptides found to 
have a direct relaxing effect on muscle (Iwakoshi et al., 
1995; Ohtani et al., 1999). Analysis of the genome of 
the sea urchin Strongylocentrotus purpuratus also 
reveals a SALMFamide gene. The gene encodes 
seven putative SALMFamide neuropeptides; 
PPVTTRSKFTFamide, DAYSAFSFamide, 
GMSAFSFamide, AQPSFAFamide, GLMPSFAFamide, 
PHGGSAFVFamide and GDLAFAFamide. These 
peptides were named SpurS1, SpurS2, SpurS3, 
SpurS4, SpurS5, SpurS6 and SpurS7, respectively. 
SpurS1, SpurS1 and SpurS3 have the C-terminal 
sequences -TFamide or -SFamide, which are identical 
or similar to the C-terminal region of the starfish 
SALMFamide S2 (Elphick and Thorndyke, 2005). The 
expression of GFSKLYFamide-like immunoreactivity in 
the digestive tract of H. scabra is remarkable as it 
underscores the potential physiological roles of the 
GFSKLYFamide-like peptide in the digestive system of 
H. scabra. Understanding for example, the potential 
effects of GFSKLYFamide neuropeptide on gastric 
motility and functions of digestive enzymes in H. 
scabra is vital, considering the economic importance of 
this species (Bai, 1971). 
In conclusion, results from this study indicate that 
GFSKLYFamide-like immunoreactivity is localized within 
the stomach and small intestines of the sea cucumber H. 





first report providing evidence for the presence of 
GFSKLYFamide neuropeptide in the digestive tract of H. 
scabra. However, further studies on the structure and 
activity of the peptide(s) producing GFSKLYFamide-
like immunoreactivity in H. scabra is warranted.   
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